Trials / Completed
CompletedNCT00895167
The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Daniel Doberer · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Heme oxygenase 1 (HO-1) serves as a protective gene. Induction of HO-1 has therapeutic potential for several indications. The inducibility of HO-1 by curcumin will be evaluated in this pilot study. Furthermore, the influence of a modulating factor of HO-1 gene activity on the dinucleotide guanosine thymine repeat (GT) length polymorphism in the promotor region will be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | curcumin | one oral dose of 12 caplets = 12 g curcumin |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-07-01
- Completion
- 2009-08-01
- First posted
- 2009-05-08
- Last updated
- 2013-01-17
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00895167. Inclusion in this directory is not an endorsement.